Test Price
2,800 AED✅ Home Collection Available
CCDC88C Gene Hydrocephalus, Nonsyndromic, Autosomal Recessive Type 1 Genetic Test in UAE
Executive Summary & Core Metrics
This next‑generation sequencing (NGS) test provides definitive molecular diagnosis for autosomal recessive hydrocephalus type 1 caused by CCDC88C gene mutations. Results are delivered within 15–21 business days with 99.9% analytical sensitivity.
- Diagnostic Accuracy: 99.9% sensitivity & specificity for all known pathogenic variants.
- Premium Logistics: VIP Mobile Phlebotomy & temperature‑controlled cold‑chain home collection (daily 8 AM–11 PM).
- Post‑Test Guidance: Telephonic clinical interpretation by a consultant medical geneticist.
- Insurance Verification: Direct billing inquiry via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The assay uses targeted NGS to sequence the entire coding region and splice junctions of CCDC88C. It detects single‑nucleotide variants, insertions/deletions, and copy‑number changes with high confidence. The method is validated under ISO 9001:2015 quality standards.
| Feature | DNA Labs UAE NGS Test | Typical Alternative (Sanger) |
|---|---|---|
| Analytical Sensitivity | 99.9% | ~95% |
| Methodology | Next‑Generation Sequencing (NGS) | Sanger sequencing (limited coverage) |
| Turnaround Time | 15–21 business days | 4–6 weeks |
Physician Insight & Safety Protocols
“This genetic test offers families a definitive molecular answer for nonsyndromic hydrocephalus. A positive result confirms the diagnosis, but a negative result does not rule out other genetic or acquired causes. Always correlate with clinical and imaging findings. Do not alter any current treatments without consulting your specialist.”
— Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
Advisory & Clinical Guidance
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic test results are intended to guide, not replace, medical management.
Safety Exclusion Criteria & Emergency Red Flags
- Acute febrile illness or active infection – defer collection.
- Anticoagulant therapy – inform phlebotomist; FTA card alternative recommended.
- Signs of raised intracranial pressure (severe headache, vomiting, blurred vision) – seek emergency care immediately.
- This test is not intended for prenatal diagnosis without prior genetic counseling.
Patient FAQ & Clinical Guidance
1. How accurate is the CCDC88C genetic test?
The NGS assay has a validated analytical sensitivity of 99.9% for all known pathogenic mutations in the CCDC88C gene, providing a definitive molecular diagnosis for autosomal recessive hydrocephalus type 1.
2. What sample is required and how is it collected?
A standard peripheral blood sample (2–5 mL) or an FTA card spot is sufficient. Our certified phlebotomist performs VIP Mobile Phlebotomy at your home or office with full cold‑chain compliance.
3. Can this test be used for family planning?
Yes. The test identifies carrier status and affected individuals, enabling informed genetic counseling and reproductive planning.
4. How long does it take to get results?
Turnaround time is 15–21 business days. For urgent cases, a VIP expedited service is available upon request.
5. Is the test covered by insurance?
We verify direct billing eligibility via WhatsApp at +971 54 548 8731 before the test. Coverage depends on your insurance plan and policy terms.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and complies with all applicable UAE federal laws:
- Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring patient data confidentiality and secure processing.
- Federal Law No. 2 of 2019 – governing the use of information and communication technology in health fields.
- Federal Decree‑Law No. 4 of 2016 on Medical Liability – safeguarding patient consent and clinical safety.
All genetic data is stored on encrypted servers with access restricted to authorized clinical personnel.
Clinical & Logistical Metadata
| Test Name | CCDC88C Gene Hydrocephalus, Nonsyndromic, Autosomal Recessive Type 1 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 15–21 business days |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or FTA card |
| Methodology Used | Next‑Generation Sequencing (NGS) – targeted gene panel |
| ICD‑10‑CM Code | Q03.8 (Other congenital hydrocephalus) |
| LOINC Code | 81247‑9 (Genetic variant detection in blood) |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians